KSM - Research and Innovation

Even in challenging times, innovation doesn't stop.

​We are proud to share that KSM’s latest research was featured this week at the European Lung Cancer Congress (ELCC) 2026 in Copenhagen.

​Though the security situation in Israel kept our team at home, our breakthrough in AI-driven lung cancer detection stood front and center on the global stage. Our Machine Learning model achieved a 90.2% AUC, identifying high-risk individuals - including never-smokers - up to 6 months before clinical diagnosis.

​At KSM, our mission to save lives through data-driven innovation remains our constant, no matter the obstacles.

We are honored to continue representing Israeli excellence in the international medical community.

On Doctors’ Day, we honor physicians whose work connects care with discovery.

Every day, doctors treat patients, make critical decisions, and improve lives. Many also transform what they see in the clinic into research that deepens medical understanding and drives progress across healthcare.
From individual patient care to large-scale studies, your work bridges practice and science - shaping better medicine for today and for the future.

Thank you for your dedication and impact.

2025 was a year of growth, scale, and impact at KSM.
Over 100 studies, 29 peer-reviewed publications, and dozens of global collaborations across medicine, genomics, and AI - all driven by a clear goal: turning data into meaningful medical research.

We’re looking ahead to 2026 with stronger infrastructure, deeper science, and new partnerships.

We deeply mourn the passing of our founding father, Morris Kahn.

Morris believed in the power of data and research to drive true innovation. This belief was central to his role
in the establishment of KSM.

May he rest in peace.

As we step into a new year, we’re reminded that progress in health and innovation is built day by day through collaboration, curiosity, and shared purpose.

Here’s to a year of meaningful research, impactful partnerships, and ideas that turn into real-world change.

Wishing our colleagues and partners a healthy, inspiring, and forward-looking year ahead.

Today we held the traditional KSM Rosh Hashanah gathering.

This past year has been remarkable: welcoming new team members, opening our dedicated Clinical Trials clinic, establishing the Bio-Convergence team, deepening global collaborations, expanding our biobank, and advancing groundbreaking research.

We believe that research and medical development truly matter for people, shaping care and improving lives. This vision reminds us of the resilience and hope that carry us forward.

Shanah Tovah to our partners, colleagues, and friends. Our hearts remain with those still held hostage in Gaza, wishing for their safe return.

Big thanks to Ido Weiner from convergebio for joining our KSM Journal Club.

We explored how GenAI and multi-omics are helping uncover disease drivers and speed up drug discovery.
A masterclass in turning data into impact.
מכבי שירותי בריאות

Thank you to Israel society of ecology and environmental sciences (isees) for the invitation to present at the Ecology & Environment Conference today at Tel Aviv University where Dr. Tal Patalon, R&D at Maccabi group shared her insights on “Risk based medicine: Geo-genetic ERA” in the Health & Environment session
האגודה הישראלית לאקולוגיה ולמדעי הסביבה מכבי שירותי בריאות
📸: [Elad Gutman]

Genetics, Health, and the Environment
📍 Join us for Dr. Tal Patalon’s upcoming session on July 8 at the Ecology & Environment Conference, Tel Aviv University.
מכבי שירותי בריאות האגודה הישראלית לאקולוגיה ולמדעי הסביבה

Big step forward at KSM:
We’ve just opened our new dedicated clinical trials clinic.

This isn’t just a space, it’s a way to bring global research closer to everyday care.

We're starting with a Phase 3 study on Retatrutide, sponsored by Eli Lilly and supported by IQVIA. Led by Prof. Adi Leiba, with our incredible clinical trials team under Galit Peretz.

Proud of what this means for research at KSM.. and for what comes next.

ADHD isn’t just a childhood condition.

At our latest KSM journal club, Dr. Gabriel Vainstein unpacked the full story of adult ADHD—its brain imaging, clinical challenges, and what often gets missed in diagnosis.

Made possible by Dr. Sivan Gazit, Head of KSM, who continues to spark the conversations that matter.

Proud moment at the Maccabi Pharmacists Conference:
🔬 Sarah Sharman Moser revealed an average 8.5-month delay from first symptom to treatment in early-stage lung cancer — highlighting the need for faster action.
💊 Vered Rosenberg showed that biologics for ankylosing spondylitis have similar real-world effectiveness — giving doctors solid data to guide care.
We’re proud of Vered, Sarah, and our entire research team, led by Dr. Sivan Gazit.
Stay tuned: More to come from KSM.
מכבי שירותי בריאות